P. Lepesant

BRAF inhibitor discontinuation and rechallenge in advanced melanoma patients with a complete initial treatment response

Céline Desvignes, Henry Abi Rached, C. Templier et al. · Melanoma Research · 2017 · 28 citations

Surgical Oncology, Brafi Therapy, Skin Cancer +13

Spindle cell tumor with <scp>CD34</scp> and <scp>S100</scp> co‐expression and distinctive stromal and perivascular hyalinization showing <scp><i>EML4‐ALK</i></scp> fusion

Diane Abs, Samuel Landman, Amélie Osio et al. · Journal of Cutaneous Pathology · 2020 · 27 citations

Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma

P. Lepesant, Marie Crinquette, Salim Alkeraye et al. · British Journal of Dermatology · 2015 · 24 citations

Surgical Oncology, Pathology, Dermatology +16

Severe skin toxicity with organ damage under the combination of targeted therapy following immunotherapy in metastatic melanoma

Marie Lamiaux, C. Scalbert, P. Lepesant et al. · Melanoma Research · 2018 · 18 citations

First-line Ttc, Therapy Combination, Immunodeficiencies +19

Comparison of sun protection modalities in parents and children

Laurent Mortier, P. Lepesant, Philippe Saïag et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 17 citations · Full text